ABBV: EU Approves MAVIRET
AbbVie's MAVIRET is approved by the European Commission for people with acute Hepatitis C Virus infection
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
AbbVie's MAVIRET is approved by the European Commission for people with acute Hepatitis C Virus infection